Perrigo Company plc (PRGO)
After hours:
| Previous Close | 30.80 |
| Open | 30.91 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1800 |
| Day's Range | 30.02 - 31.05 |
| 52 Week Range | 25.77 - 40.28 |
| Volume | |
| Avg. Volume | 1,997,800 |
| Market Cap | 4.074B |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 |
| Earnings Date | May 07, 2024 - May 13, 2024 |
| Forward Dividend & Yield | 1.10 (3.64%) |
| Ex-Dividend Date | Mar 07, 2024 |
| 1y Target Est | 40.50 |
Insider MonkeyHere’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]
FortuneThe WNBA has partnered with Glossier and Skims—now it’s added Opill, the new over-the-counter birth control
Pharma company Perrigo plans to spread the word about Opill at the WNBA draft.
PR NewswireOpill and WNBA Team Up for Groundbreaking Partnership
Today, Perrigo Company plc, a leading provider of Consumer Self-Care Products, announced that Opill® — the first-ever daily birth control pill available without a prescription in the U.S. — and the Women's National Basketball Association (WNBA) have entered a multi-year partnership that focuses on building confidence, strength and health equity, all of which closely align with both organizations' core priorities.
